Skopin II, Latyshev MS, Britikov DV, Slivneva IV. Implantation of a mitral allograft into the tricuspid valve position in active infective endocarditis.
Indian J Thorac Cardiovasc Surg 2024;
40:711-715. [PMID:
39416341 PMCID:
PMC11479642 DOI:
10.1007/s12055-024-01712-x]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 02/14/2024] [Accepted: 02/23/2024] [Indexed: 10/19/2024] Open
Abstract
In cases of severe and recurrent infectious lesions affecting the right heart, one alternative option for bioprosthetic intervention is the implantation of a mitral allograft (a donor heart valve) in the position of the tricuspid valve. We present a clinical case detailing the successful implantation of a fresh mitral allograft into the tricuspid position in a 37-year-old male patient diagnosed with active infective endocarditis of the tricuspid valve and a high risk of prosthetic endocarditis. The mitral allograft was anatomically implanted with annuloplasty using an expanded polytetrafluoroethylene band. Subsequently, the patient was discharged in satisfactory condition. During the 9-month follow-up examination, no signs of infection were observed. Furthermore, the mitral allograft demonstrated excellent functionality, as evidenced by the absence of regurgitation and a mean pressure gradient measuring only 2 mmHg.
Collapse